Figure 11.
Synergistic action between D1 and D2 dopamine receptors in alleviating the immobility of a Parkinson's diseased patient. Lisuride has a predominantly D2 action (see Table 2) while L-DOPA results in the synthesis of dopamine, which activates both D1 and D2. The patient's mobility is sustained on the combined activation of D1 and D2. (adapted from ref. 124)
Back to Chapter

published 2000